imipenem, anhydrous has been researched along with Endophthalmitis in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (11.76) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 3 (17.65) | 2.80 |
Authors | Studies |
---|---|
Agrawal, KU; Gad, M; Limaye Joshi, K | 1 |
Corrales, MI; Galvis, V; Garcia, D; Parra, MM; Rangel, CM; Sánchez-Ávila, R; Tello, A; Varón, CL; Villareal, E; Villarreal, D | 1 |
Agarwal, M; Gandhi, A; Mayor, R; Paul, L; Ranjan, R; Singh, S | 1 |
Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C | 1 |
Kim, KH; Lee, JY | 1 |
de Haller, R; Mavrakanas, TA; Philippe, J | 1 |
Das, T; Dave, VP; Jalali, S; Mathai, A; Narayanan, R; Nishant, K; Pappuru, RR; Pathengay, A; Sharma, P; Sharma, S | 1 |
Engelbert, M; Grasbon, T; Kampik, A; Klauss, V; Miño de Kaspar, H; Ta, CN; Thiel, M | 1 |
Engelbert, M; Grasbon, T; Kampik, A; Klauss, V; Mette, M; Miño de Kaspar, H; Schulze-Schwering, M; Ta, CN; Thiel, M | 1 |
Engelbert, M; Grasbon, T; Kampik, A; Klauss, V; Miño de Kaspar, H; Schulze-Schwering, M; Ta, CN; Thiel, M | 1 |
De Kaspar, HM; Engelbert, M; Kampik, A; Mette, M; Ta, CN; Thiel, M | 1 |
Körner, F; Wolfensberger, TJ | 1 |
Alfaro, DV; Bevin, AA; Hudson, SJ; Laughlin, RM; Mines, M; offele, JJ; Schoderbek, RJ | 1 |
Alfaro, DV; Barton, CP; Beverly, DT; Brucker, AJ; Hudson, SJ; Kasowski, EJ; King, LP; Lopez, JD | 1 |
D'Amico, DT; Ng, EW | 1 |
Barza, M; Davey, PG; Stuart, M | 1 |
Axelrod, JL; Bergen, RL; Klein, RM; Newton, JC; Sheikh, MZ | 1 |
1 review(s) available for imipenem, anhydrous and Endophthalmitis
Article | Year |
---|---|
A Rare Case of Fulminant Acute Postoperative Morganella morganii Endophthalmitis.
Topics: Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Imipenem; Middle Aged; Morganella morganii; Postoperative Complications; Visual Acuity; Vitrectomy; Vitreous Body | 2023 |
16 other study(ies) available for imipenem, anhydrous and Endophthalmitis
Article | Year |
---|---|
ENDOPHTHALMITIS IN OPHTHALMOLOGICAL REFERRAL CENTRE IN COLOMBIA: AETIOLOGY AND MICROBIAL RESISTANCE.
Topics: Adult; Anti-Bacterial Agents; Colombia; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Imipenem; Male; Moxifloxacin; Referral and Consultation; Retrospective Studies; Vancomycin | 2022 |
Microbiological and Antibiotic Sensitivity Profile of Postoperative Endophthalmitis in a Tertiary Eye Care Hospital of North India.
Topics: Agar; Aged; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Retrospective Studies; Tertiary Care Centers; Vancomycin; Vitrectomy | 2021 |
[Endogenous endophthalmitis as a complication in erysipelas].
Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin | 2013 |
Endogenous endophthalmitis complicated by pyogenic liver abscess: a review of 17 years' experience at a single center.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Diabetes Complications; Endophthalmitis; Female; Humans; Imipenem; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Male; Middle Aged; Risk Factors; Treatment Outcome | 2014 |
Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Endophthalmitis; Female; Foot Diseases; Humans; Imipenem; Osteomyelitis; Radiography; Vancomycin | 2015 |
Clinical presentations, risk factors and outcomes of ceftazidime-resistant Gram-negative endophthalmitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Cephalosporin Resistance; Child; Child, Preschool; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Body | 2017 |
Intravenous imipenem prophylaxis in experimental endophthalmitis.
Topics: Animals; Antibiotic Prophylaxis; Colony Count, Microbial; Endophthalmitis; Eye Infections, Bacterial; Female; Imipenem; Injections, Intravenous; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vitreous Body | 2002 |
Intravenous treatment of experimental Staphylococcus aureus endophthalmitis: imipenem versus the combination of ceftazidime and amikacin.
Topics: Amikacin; Animals; Ceftazidime; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Imipenem; Injections, Intravenous; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vitreous Body | 2003 |
Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.
Topics: Amikacin; Animals; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Imipenem; Injections, Intravenous; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2004 |
Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Imipenem; Injections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2008 |
[Change in therapy of acute endophthalmitis: an analysis of 92 cases 1980-1993].
Topics: Acute Disease; Cataract Extraction; Ciprofloxacin; Combined Modality Therapy; Endophthalmitis; Follow-Up Studies; Humans; Imipenem; Infusions, Intravenous; Postoperative Complications; Retrospective Studies; Visual Acuity; Vitrectomy | 1995 |
Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacillaceae Infections; Bacillus cereus; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pilot Projects; Random Allocation; Retinitis; Swine; Thienamycins; Vancomycin; Vitreous Body | 1996 |
Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Follow-Up Studies; Imipenem; Injections; Pseudomonas aeruginosa; Pseudomonas Infections; Sclera; Swine; Thienamycins; Vitreous Body | 1997 |
Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pseudomonas Infections; Swine; Vitreous Body | 1997 |
Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections.
Topics: Animals; Ciprofloxacin; Dose-Response Relationship, Drug; Endophthalmitis; Gentamicins; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Thienamycins; Time Factors; Vitreous Body | 1987 |
Penetration of imipenem into human aqueous and vitreous humor.
Topics: Aqueous Humor; Endophthalmitis; Humans; Imipenem; Nausea; Osmolar Concentration; Thienamycins; Vitreous Body | 1987 |